Featured in brca2
Major U.S. Company Makes A Breast Cancer Risk Test Using Once-Patented Genes
Just four months after the U.S. Supreme Court ruled genes can't be patented, Myriad Genetics is seeing some competition.
What’s Next For Gene Patenting?
We take a look at how yesterday's Supreme Court ruling affects risk testing for breast cancer. Plus, this isn't the last word for gene patenting.
U.S. Supreme Court Rules On Gene Patents
Naturally occurring genes cannot be patented, but synthetic ones can.
Should Companies Be Able To Patent Genes?
Opponents to gene patenting have lost their case in courts before, but they're now trying the U.S. Supreme Court.